BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28205365)

  • 1. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
    Rogers T; Minard-Colin V; Cozic N; Jenney M; Merks JHM; Gallego S; Devalck C; Gaze MN; Kelsey A; Oberlin O; Stevens M; Spicer RD; Bergeron C; Martelli H
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
    Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
    Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
    J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma.
    Goldfarb B; Khoury AE; Greenberg ML; Churchill BM; Smith CR; McLorie GA
    J Urol; 1994 Aug; 152(2 Pt 2):785-7. PubMed ID: 8022014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment results in children with malignant mesenchymal tumors according to the protocols of the International Society of Pediatric Oncology (SIOP)].
    López Pérez J; Melero Moreno C; Vivanco Martínez JL; Torres Valdivieso MJ; Cela de Julián E
    An Esp Pediatr; 1996 Jun; 44(6):557-60. PubMed ID: 8849098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal lymph node staging in paratesticular rhabdomyosarcoma-are we meeting expectations?
    Hamilton EC; Miller CC; Joseph M; Huh WW; Hayes-Jordan AA; Austin MT
    J Surg Res; 2018 Apr; 224():44-49. PubMed ID: 29506850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
    J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paratesticular rhabdomyosarcoma: results of therapy in 18 cases.
    Blyth B; Mandell J; Bauer SB; Colodny AH; Grier HE; Weinstein HJ; Tarbell NJ; Hendren WH; Retik AB
    J Urol; 1990 Dec; 144(6):1450-3. PubMed ID: 2122010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
    Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE
    Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
    Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
    Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
    Orbach D; Mosseri V; Gallego S; Kelsey A; Devalck C; Brenann B; van Noesel MM; Bergeron C; Merks JH; Rechnitzer C; Jenney M; Minard-Colin V; Stevens M
    Head Neck; 2017 Jan; 39(1):24-31. PubMed ID: 27459057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
    Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
    Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
    J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paratesticular rhabdomyosarcoma in children.
    Quesada EM; Diez B; Silva M; Muriel FS; Chemes H
    J Urol; 1986 Jul; 136(1 Pt 2):303-4. PubMed ID: 3723682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of alveolar rhabdomyosarcoma in childhood. An International Society of Pediatric Oncology study.
    Reboul-Marty J; Quintana E; Mosseri V; Flamant F; Asselain B; Rodary C; Zucker JM
    Cancer; 1991 Aug; 68(3):493-8. PubMed ID: 2065269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.
    Dang ND; Dang PT; Samuelian J; Paulino AC
    Cancer; 2013 Sep; 119(17):3228-33. PubMed ID: 23744806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging paratesticular rhabdomyosarcoma in the "as low as reasonably achievable" age: the case for PET-CT.
    Burnette JO; Klaassen Z; Hatley RM; Neunert CE; Williams H; Donohoe JM
    Urology; 2013 Jul; 82(1):220-3. PubMed ID: 23352374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.